MYD88 and B-cell chronic lymphocytic leukemia: Since the MYD88 mutation is harboring in 1–10% CLL patients, the current study aimed to characterize the association between expression and mutational status of MYD88 and TLRs expression in the bone marrow and peripheral blood in CLL.